This site is intended for health professionals only

At the heart of general practice since 1960

pulse june2020 80x101px
Read the latest issue online

The waiting game

Bisphosphonates cut elasticity of bones

Clopidogrel is cost-effective in combination with aspirin for treating patients with high-risk acute coronary syndromes, researchers conclude.

The US study, published in the Annals of Internal Medicine, found clopidogrel increased quality of life years to 9.61 from 9.51 with aspirin alone.

The cost of adding in clopidogrel was $15,400 per quality of life year gained, or £8,060, compared with a standard threshold for cost-effectiveness of £30,000.

The researchers, from Stanford University Medical Centre in California, compared patients receiving clopidogrel and aspirin for a year followed by aspirin monotherapy with those receiving aspirin alone.

It comes after a recent study in the New England Journal of Medicine question-ed the use of clopidogrel in patients with a history of aspirin-induced ulcer bleeding.

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say